These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 37176536)

  • 21. Methylphenidate in Adults with Attention Deficit Hyperactivity Disorder and Substance Use Disorders.
    Simon N; Rolland B; Karila L
    Curr Pharm Des; 2015; 21(23):3359-66. PubMed ID: 26088112
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacological treatment for attention deficit hyperactivity disorder (ADHD) in children with comorbid tic disorders.
    Osland ST; Steeves TD; Pringsheim T
    Cochrane Database Syst Rev; 2018 Jun; 6(6):CD007990. PubMed ID: 29944175
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacological and clinical dilemmas of prescribing in co-morbid adult attention-deficit/hyperactivity disorder and addiction.
    Pérez de los Cobos J; Siñol N; Pérez V; Trujols J
    Br J Clin Pharmacol; 2014 Feb; 77(2):337-56. PubMed ID: 23216449
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Attention Deficit Hyperactivity Disorder and Substance Use Disorder: A Narrative Review.
    Srichawla BS; Telles CC; Schweitzer M; Darwish B
    Cureus; 2022 Apr; 14(4):e24068. PubMed ID: 35573587
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Substance abuse in patients with attention-deficit/hyperactivity disorder.
    Bukstein O
    Medscape J Med; 2008 Jan; 10(1):24. PubMed ID: 18324334
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A review of the efficacy of atomoxetine in the treatment of attention-deficit hyperactivity disorder in children and adult patients with common comorbidities.
    Clemow DB; Bushe C; Mancini M; Ossipov MH; Upadhyaya H
    Neuropsychiatr Dis Treat; 2017; 13():357-371. PubMed ID: 28223809
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The clinical course of comorbid substance use disorder and attention deficit/hyperactivity disorder: protocol and clinical characteristics of the INCAS study.
    Brynte C; Aeschlimann M; Barta C; Begeman AHA; Bäcker A; Crunelle CL; Daigre C; De Fuentes-Merillas L; Demetrovics Z; Dom G; López LG; Icick R; Johnson B; Joostens P; Kapitány-Fövény M; Karsinti E; Kiefer F; Konstenius M; Levin FR; Luderer M; Markus W; Matthys F; Moggi F; Palma-Alvarez RF; Paraskevopoulou M; Ramos-Quiroga JA; Schellekens A; Soravia LM; Therribout N; Thomas A; van de Glind G; van Kernebeek MW; Vollstädt-Klein S; Vorspan F; van den Brink W; Franck J
    BMC Psychiatry; 2022 Sep; 22(1):625. PubMed ID: 36151539
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adult Attention-Deficit Hyperactivity Disorder/Substance Use Disorder Dual Disorder Patients: A Dual Disorder Unit Point of View.
    Maremmani I; Spera V; Maiello M; Maremmani AGI; Perugi G
    Curr Top Behav Neurosci; 2022; 57():179-198. PubMed ID: 35507285
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of Substance Misuse and Family History of Substance Use Disorder on Delay Discounting in Adolescents and Young Adults with Attention-Deficit/Hyperactivity Disorder.
    Paraskevopoulou M; van Rooij D; Schene AH; Scheres APJ; Buitelaar JK; Schellekens AFA
    Eur Addict Res; 2020; 26(4-5):295-305. PubMed ID: 32659779
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacological interventions for adolescents and adults with ADHD: stimulant and nonstimulant medications and misuse of prescription stimulants.
    Weyandt LL; Oster DR; Marraccini ME; Gudmundsdottir BG; Munro BA; Zavras BM; Kuhar B
    Psychol Res Behav Manag; 2014; 7():223-49. PubMed ID: 25228824
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk of serious cardiovascular problems with medications for attention-deficit hyperactivity disorder.
    Martinez-Raga J; Knecht C; Szerman N; Martinez MI
    CNS Drugs; 2013 Jan; 27(1):15-30. PubMed ID: 23160939
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Attention Deficit Hyperactivity Disorder in Prisoners: Increased Substance Use Disorder Severity and Psychiatric Comorbidity.
    Vélez-Pastrana MC; González RA; Ramos-Fernández A; Ramírez Padilla RR; Levin FR; Albizu García C
    Eur Addict Res; 2020; 26(4-5):179-190. PubMed ID: 32615575
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and safety limitations of attention-deficit hyperactivity disorder pharmacotherapy in children and adults.
    Wigal SB
    CNS Drugs; 2009; 23 Suppl 1():21-31. PubMed ID: 19621975
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The dark side of ADHD - comorbidity with substance use disorder and criminality - an overview].
    Johansson Capusan A; Guterstam J; Ginsberg Y; Borg Skoglund L
    Lakartidningen; 2022 Feb; 119():. PubMed ID: 36794414
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Attention-deficit/hyperactivity disorder subtypes in adolescents with comorbid substance-use disorder.
    Tamm L; Adinoff B; Nakonezny PA; Winhusen T; Riggs P
    Am J Drug Alcohol Abuse; 2012 Jan; 38(1):93-100. PubMed ID: 21834613
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Attention-deficit/hyperactivity disorder and early-onset substance use disorders.
    Wilson JJ; Levin FR
    J Child Adolesc Psychopharmacol; 2005 Oct; 15(5):751-63. PubMed ID: 16262592
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential diagnosis, comorbidity, and treatment of attention-deficit/hyperactivity disorder in relation to bipolar disorder or borderline personality disorder in adults.
    Asherson P; Young AH; Eich-Höchli D; Moran P; Porsdal V; Deberdt W
    Curr Med Res Opin; 2014 Aug; 30(8):1657-72. PubMed ID: 24804976
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The complexity of ADHD: diagnosis and treatment of the adult patient with comorbidities.
    Newcorn JH; Weiss M; Stein MA
    CNS Spectr; 2007 Aug; 12(8 Suppl 12):1-14; quiz 15-6. PubMed ID: 17667893
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Methylphenidate. Therapy option for adults with ADHD and comorbid substance use disorder?].
    Paslakis G; Kiefer F; Diehl A; Alm B; Sobanski E
    Nervenarzt; 2010 Mar; 81(3):277-88. PubMed ID: 20108084
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Psychiatric comorbidity in treatment-seeking substance use disorder patients with and without attention deficit hyperactivity disorder: results of the IASP study.
    van Emmerik-van Oortmerssen K; van de Glind G; Koeter MW; Allsop S; Auriacombe M; Barta C; Bu ET; Burren Y; Carpentier PJ; Carruthers S; Casas M; Demetrovics Z; Dom G; Faraone SV; Fatseas M; Franck J; Johnson B; Kapitány-Fövény M; Kaye S; Konstenius M; Levin FR; Moggi F; Møller M; Ramos-Quiroga JA; Schillinger A; Skutle A; Verspreet S; ; van den Brink W; Schoevers RA
    Addiction; 2014 Feb; 109(2):262-72. PubMed ID: 24118292
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.